News | February 06, 2007

New HF Procedure Uses Stem Cells from Patient’s Fat Tissue

Feb. 7, 2007 — A first ever human procedure in Madrid took place this week in which a heart failure patient received adult stem cells removed from his own adipose (fat) tissue by liposuction. The cells were processed and injected directly into the heart muscle with a special catheter.

Cytori Therapeutics Inc. developed the proprietary, one-hour method through which stem cells are processed. After processing, stem cells are injected directly into damaged but viable areas of the heart muscle through an investigational device called a NOGA catheter, which allows 3D color-coded maps of the mechanical and electrical function of the heart’s left ventricle.

The procedure was part of a collaborative trial led by the Texas Heart Institute at St. Luke’s Episcopal Hospital that will involve 30 patients. Francisco Fernandez-Avilés, M.D. performed the procedure at Hospital General Universitario Gregorio Marañón in Madrid, Spain — he is Professor of Cardiovascular Medicine and Chief of Cardiology Service at Gregorio Marañón. He is co-principal investigator in the trial with Emerson Perin, M.D., director of New Interventional Cardiovascular Technology and director of Stem Cell Center at the Texas Heart Institute at St. Luke’s.

“This is the first time we have used adipose-derived stem cells in humans. We had good results in our pre-clinical tests and we are excited about taking this research to the next level,” said Dr. Perin.

For more information visit www.

Related Content

Placental Stem Cells Can Regenerate the Heart After Heart Attack
News | Stem Cell Therapies | May 20, 2019
Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated that stem cells derived from the placenta...
ProxiCor Extracellular Matrix Reduces Complications, Readmissions Following Pericardial Reconstruction
News | Stem Cell Therapies | April 19, 2019
Aziyo Biologics Inc. announced the publication of results from its landmark RECON study in the Journal of...
FDA Releases Final Guidances on Regenerative Medicine Therapies
News | Stem Cell Therapies | March 04, 2019
The U.S. Food and Drug Administration (FDA) recently finalized two guidance documents regarding regenerative medicine...
Heart Muscle Cells Created From Stem Cells Beat in Sync
News | Stem Cell Therapies | February 01, 2019
A team of Rutgers scientists have taken an important step toward the goal of making diseased hearts heal themselves – a...
FDA Clamps Down on Unapproved Stem Cell Therapies
News | Stem Cell Therapies | December 20, 2018
December 20, 2018 — The U.S.
Secant Introduces First Synthetic Regenerative Cardiovascular Graft for CABG
News | Stem Cell Therapies | January 17, 2018
Secant Group, in partnership with its sister company SanaVita Medical, announced new technology to advance...
News | Stem Cell Therapies | October 24, 2017
October 24, 2017 — Roche and Ncardia have reached a broad licensing agreement whereby Roche and its affiliate compani
BioCardia Announces 12-Month Results from TRIDENT Trial of Stem Cell Delivery System
News | Stem Cell Therapies | September 26, 2017
BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT clinical trial, conducted by the...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies | August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Overlay Init